Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,103Revenue $M45.6Net Margin (%)-601.7Z-Score-2.4
Enterprise Value $M1,091EPS $-1.5Operating Margin %-600.4F-Score3
P/E(ttm))0Cash Flow Per Share $-0.8Pre-tax Margin (%)-600.8Higher ROA y-yY
Price/Book8.910-y EBITDA Growth Rate %0Quick Ratio5.1Cash flow > EarningsY
Price/Sales22.45-y EBITDA Growth Rate %0Current Ratio5.1Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-73.9Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)1ROE % (ttm)-147.8Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M187ROI % (ttm)-83.9Gross Margin Increase y-yN

Gurus Latest Trades with ARIA

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
Current Price Change from Average Comment Current Shares
ARIAGeorge Soros 2014-06-30 Add0.02%$6.3 - $8.52
$ 5.9-14%Add 100%1,000,000
ARIAGeorge Soros 2014-03-31 Reduce-0.08%$6.46 - $8.99
$ 5.9-24%Reduce -74.36%500,000
ARIAGeorge Soros 2013-12-31 Buy 0.11%$2.2 - $18.8
$ 5.914%New holding, 1950000 sh.1,950,000
ARIADaniel Loeb 2013-06-30 Sold Out -0.94%$16.32 - $19.77
$ 5.9-67%Sold Out0
ARIADaniel Loeb 2012-12-31 Add0.4%$18.93 - $25.16
$ 5.9-73%Add 85.19%2,500,000
ARIADaniel Loeb 2012-09-30 Reduce-0.39%$17.11 - $24.21
$ 5.9-70%Reduce -35.71%1,350,000
ARIADaniel Loeb 2012-06-30 Buy 1.1%$14.6 - $17.82
$ 5.9-64%New holding, 2100000 sh.2,100,000
ARIAGeorge Soros 2012-06-30 Sold Out -0.15%$14.6 - $17.82
$ 5.9-64%Sold Out0
ARIAGeorge Soros 2012-03-31 Buy 0.15%$12.73 - $16.32
$ 5.9-57%New holding, 635000 sh.635,000
ARIAGeorge Soros 2011-12-31 Sold Out -0.07%$8.03 - $12.5
$ 5.9-46%Sold Out0
ARIAGeorge Soros 2011-09-30 Buy 0.07%$7.63 - $13.34
$ 5.9-44%New holding, 496847 sh.496,847
ARIAJean-Marie Eveillard 2008-06-30 Buy $2.39 - $3.57
$ 5.9111%New holding, 50000 sh.50,000
ARIAGeorge Soros 2008-06-30 Sold Out -0.01%$2.39 - $3.57
$ 5.9111%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ARIA is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
ARIA George Soros 2014-06-301,000,0000.540.05+100%
Premium Most recent portfolio changes are included for Premium Members only!

ARIA: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
DENNER ALEXANDER JDirector 2014-08-15Buy850,000$5.833.95view
Cantor Maria ESVP, Corporate Affairs and HR 2014-06-02Sell3,713$6.9-12.17view
Haluska FrankSVP, Clinical R&D, CMO 2014-04-02Sell3,400$8.21-26.19view
BERSTEIN DAVID LSVP, GC and Chief IP Officer 2014-04-02Sell2,400$8.22-26.28view
Bollag Daniel MSr. VP, Reg. Affairs & Quality 2014-04-02Sell2,400$8.22-26.28view
Cantor Maria ESVP, Corporate Affairs and HR 2014-04-02Sell4,250$8.21-26.19view
CLACKSON TIMOTHY PPresident, R&D, CSO 2014-04-02Sell6,500$8.21-26.19view
Cantor Maria ESVP, Corporate Affairs and HR 2014-03-21Sell3,667$7.89-23.19view
BERSTEIN DAVID LSVP, GC and Chief IP Officer 2014-03-21Sell1,600$7.89-23.19view
Haluska FrankSVP, Clinical R&D, CMO 2014-03-21Sell2,400$7.89-23.19view

Press Releases about ARIA :

Quarterly/Annual Reports about ARIA:

News about ARIA:

Articles On GuruFocus.com
Sarah Ketterer of Causeway Capital's Answers to GuruFocus Q&A Apr 07 2014 
Weekly CEO Sells Highlight: U.S. Bancorp, Restoration Hardware Holdings Inc, Ariad Pharmaceuticals, Jul 20 2013 
Daniel Loeb's Top Three Increases of the First Quarter May 24 2013 
comment on ARIA Mar 15 2013 
comment on ARIA Mar 15 2013 
comment on ARIA May 16 2012 
Weekly CFO Sales Highlight: WWWW, FIO, CRIS, ARIA, VOG, APKT Apr 22 2012 
3 Biotech Stocks To Consider Buying Right Now Jan 10 2012 
ARIAD Pharmaceuticals Inc. Reports Operating Results (10-K) Mar 15 2011 
creiter note on ARIA Jan 03 2010 

More From Other Websites
Nasdaq stocks posting largest percentage increases Aug 20 2014
ARIAD Falls on Wider-than-Expected Loss, Revenues Miss Aug 11 2014
ARIAD PHARMACEUTICALS INC Files SEC form 8-K, Other Events Aug 08 2014
Why Ariad Pharmaceuticals (ARIA) Stock Is Down Today Aug 06 2014
ARIAD Pharmaceuticals Inc Earnings Call scheduled for 8:30 am ET today Aug 06 2014
ARIAD PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Aug 06 2014
ARIAD Reports Second Quarter 2014 Financial Results and Development Progress Aug 06 2014
Q2 2014 ARIAD Pharmaceuticals, Inc. Earnings Release - Before Market Open Aug 06 2014
Will GW Pharmaceuticals (GWPH) Miss this Earnings Season? Aug 05 2014
ARIAD Announces Commercial Agreement for Iclusig (Ponatinib) in Israel Aug 05 2014
Should You Sell Ariad Pharmaceuticals (ARIA) Before Earnings? Aug 05 2014
The Zacks Analyst Blog Highlights: AbbVie, Shire, ARIAD Pharmaceuticals, ImmunoGen and Durata... Aug 01 2014
Storm The Castle: ARIAD Pharmaceuticals (ARIA) Jul 29 2014
ARIAD Pharmaceuticals (ARIA) Showing Signs Of Perilous Reversal Today Jul 25 2014
Ariad Pharmaceuticals (ARIA) Worth Watching: Stock Gains 15.3% Jul 24 2014
ARIAD to Webcast Conference Call on Second Quarter 2014 Financial Results Jul 16 2014
ARIAD to Webcast Conference Call on Second Quarter 2014 Financial Results Jul 16 2014
ARIAD Announces Continuation of Iclusig Review under the Article 20 Procedure in Europe Jul 14 2014

Add Notes, Comments or Ask Questions

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
Email Hide